Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma
Novartis
Novartis
MEI Pharma, Inc.
Atara Biotherapeutics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Incyte Corporation
Roswell Park Cancer Institute
Adicet Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Aprea Therapeutics
Janssen Research & Development, LLC
Oncternal Therapeutics, Inc
University of Wisconsin, Madison
Genmab
Academic and Community Cancer Research United
Taiho Oncology, Inc.
Columbia University
Columbia University
IGM Biosciences, Inc.
MingSight Pharmaceuticals, Inc
Amgen
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
BioNova Pharmaceuticals (Shanghai) LTD.
ADC Therapeutics S.A.
Prelude Therapeutics
Stanford University
University of Alabama at Birmingham
University of Nebraska
Polish Lymphoma Research Group
Exelixis
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
Asana BioSciences
MEI Pharma, Inc.
AbbVie
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
TG Therapeutics, Inc.
Eden BioCell Ltd.
TG Therapeutics, Inc.
M.D. Anderson Cancer Center
Swiss Cancer Institute
Brown University
The First Affiliated Hospital with Nanjing Medical University
ADC Therapeutics S.A.
Weill Medical College of Cornell University
Northwestern University